Lizzo is getting things done. The singer has been updating her followers on her weight loss process, sharing videos and ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Throughout her career Lizzo has shared details about her health journey, explaining that she’s not interested in doing ...

"Today, we have GLP-1s designed specifically for weight loss and there is greater public awareness around the benefits of these medications." ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Lizzo has lost nearly 16 percent body fat in her ongoing weight loss journey and says that she’s ‘happy’ with the progress ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

Many people struggle to maintain a healthy weight, and choosing the optimal meals for weight loss can be challenging. A research team has developed a weight management program that helps individuals ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...